Merging diverse epitopes onto a single carrier platform overcomes insufficient clinical efficacy of conventional single-antigen vaccines.
Recombinant Salmonella displays Campylobacter jejuni N-glycans on its surface, bypassing complex chemical conjugation and molecular mimicry issues.
Subcritical water processing isolates parthenolide-free feverfew fractions, resolving allergenicity risks while maintaining anti-inflammatory activity.
A BLS-Stx2B chimera fuses Shiga toxin B subunits to a stable scaffold, creating oligomeric complexes that enhance immunogenicity.
Trehalose forms a protective glassy matrix around aluminum-salt adjuvants during lyophilization, preventing particle aggregation and preserving immunogenicity.
Lactoperoxidase and cationic milk proteins selectively inhibit pathogenic microorganisms while preserving commensal flora.
Segmenting antibacterial spectra via drug pairs preserves gut microbiota integrity while effectively treating resistant infections.
Boronic acid derivatives inhibit beta-lactamase enzymes, preserving traditional antibiotic effectiveness against multidrug-resistant bacterial strains.
Near-neutral pH and enzyme formulations detach biofilms in sinus cavities, eliminating deciliation risks associated with acidic surfactants.
Spherical chlorhexidine crystals switch to sustained release via pH changes, solving burst delivery limitations in periodontal treatment.
Modifying antibody complementarity determining regions enables broad-spectrum neutralization of diverse Staphylococcus aureus strains including MRSA.
Formula I compounds selectively inhibit 11beta-HSD1 in adipose tissue, reducing systemic side effects while treating metabolic syndrome.
Extracted 55 kDa protein from Photobacterium damselae elicits neutralizing antibodies, reducing fish mortalities from pasteurellosis.
Topical compositions containing prostaglandins address chronic inflammation to restore brittle nails without systemic administration.
Transglutaminase mediates site-specific polymer conjugation to G-CSF, extending circulating half-life and reducing dosing frequency.
Fully human monoclonal antibodies bind to hLIGHT polypeptides, blocking HVEM and LTβR receptors to reduce inflammatory cytokine secretion.
Recombinant flagellin fused with pneumococcal antigen activates toll-like receptor 5 to enhance immunity.
Chondroitin sulfate compounds bind to histones to neutralize cellular toxicity and reduce organ damage in sepsis treatments.
Biphasic crystallization of anhydrous form C resolves polymorphic instability in existing forms, enabling reliable industrial manufacturing.
Replacing cysteine residues with serine or alanine prevents covalent dimer formation, resolving antigen instability issues in vaccine formulations.
Merges chlorhexidine digluconate with prednisolone acetate to provide broad-spectrum antimicrobial action while minimizing sensitivity reactions.
Quenched benzophenothiazinium chloride conjugated to a cephalosporin linker activates fluorescence upon beta-lactamase cleavage.
N-acetyl-lactosamine oligosaccharides combine with Lactobacillus to reduce pathogen adherence on intestinal epithelium.
Pentahydrate copper salts and heptahydrate zinc salts maintain antibacterial efficacy in organic matter, preventing bovine mastitis.
GAPDH-derived peptides elicit specific antibodies to neutralize bacterial virulence factors, addressing antibiotic resistance and neonatal immune immaturity.
Topical immunoglobulin A and secretory component formulations stabilize mucosal contact to inhibit microbial adherence.
Functionalized carbon dots achieve broad-spectrum virucidal activity against SARS-CoV-2 by converting light energy into chemical reactive oxygen species.
Salacia extract suppresses Lachnospiraceae and Ruminococcaceae to alleviate inflammatory bowel disease symptoms.
Silicone patch delivers controlled potassium permanganate doses to treat skin disorders while preventing chemical burns and antimicrobial resistance.
A herbal composition combining specific herbs and minerals to treat infectious diseases.
Combines multiplex PCR detection with pooled antibiotic susceptibility testing to identify polymicrobial infections.
Hetero-halo compounds resolve the selectivity trade-off by specifically inhibiting HDAC2, enhancing synaptic density without off-target effects.
Synthetic lipid vesicles detect membrane-lytic toxins to monitor bacterial quorum sensing density.
Engineered mycobacteria over-express antigens via electroporation, extending immunity beyond early childhood.
Altering helical folding in antimicrobial peptoids resolves the trade-off between enzymatic stability and cytotoxicity, enabling selective bacterial targeting.
Chronic inhaled alpha1-proteinase inhibitor prevents repetitive pulmonary exacerbations by maintaining continuous neutrophil elastase inhibition.
Novel piperazine-piperidine compounds modulate CXCR3 receptor activity to treat inflammatory and autoimmune diseases.
Conjugated oligoelectrolytes destroy resistant bacteria through membrane disruption while minimizing mammalian cell toxicity.
Ionic liquid solvents enable efficient synthesis of imidazole antimicrobials, eliminating hazardous volatile organic compounds from the reaction process.
Stabilized silver salt and acemannan hydrogel reduces bioburden and pain while accelerating healing in infected wounds.
PlyCP endolysins degrade peptidoglycan cell walls of Clostridium perfringens, providing specific antimicrobial activity without inducing antibiotic resistance.
Lactobacillus paracasei K71 fermented rice facilitates secretory immunoglobulin A production and activates natural killer cells.
Specific amino acid mutations in tear lipocalin muteins enhance binding affinity for IL-4 receptor alpha, resolving low affinity limitations.
Derivatizing nystatin at the C28-C29 position reduces toxicity while maintaining antifungal efficacy, resolving the contradiction between safety and potency.
Substituted biphenyl amides selectively antagonize P2X3 receptors to treat genitourinary disorders and pain conditions.
A composite thickening system stabilizes dentifrice viscosity using polyvinylpyrrolidone, polysaccharide gum, and carboxymethyl cellulose.
Replacing thimerosal with specific polyamides or octenidine eliminates irritation and environmental harm while maintaining antimicrobial protection.
Synthetic compounds stabilize endothelial tight junctions to reduce vascular permeability while enabling commercial synthesis feasibility.
Local inhalation of antidepressants inhibits acid sphingomyelinase to normalize ceramide levels, avoiding systemic side effects from high oral dosages.